Methadone is an opioid agonist medication that has been used to treat opioid use disorder (OUD) for 50 years. Methadone reduces opioid craving and withdrawal and blunts or blocks the effects of opioids. As with all medications used in medications for addiction treatment (MAT), methadone is prescribed as part of a comprehensive treatment plan.
Methadone, which is also used to treat pain, can cause adverse effects, including overdose, if not taken as prescribed. By law, patients taking methadone to treat OUD must receive the medication under the supervision of a physician, and methadone is only dispensed through a SAMHSA-certified opioid treatment program (OTP).
Related Training Resources
Administrative Staff, Counselors, Family and Patient, Interprofessional Teams, Judges, Nurses, Pharmacists, Physician Assistants, Physicians, Psychiatrists, Social Workers
Presenter(s):
Darrell Mitchell, Founder of INARR, President of NARR, Vice President of Recovery Communities at Aspire Indiana Health, and Executive Director of Progress House
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME, Social Work CE Credit, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Despite significant evidence of their effectiveness and efficacy, individuals across the country are still facing barriers to care associated with the stigma surrounding medications for opioid use disorder (MOUD). One recent peer-reviewed study found that of 360 facilities supporting individuals with opioid-related needs, one fourth were unwilling to serve individuals receiving MOUD (Kepple et al., 2019). For those seeking recovery housing, this unwillingness can mean choosing between their life-saving medications and a safe, supportive place to live.
Counselors, Interprofessional Teams, Nurses, Physician Assistants, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Presenter(s):
Robert Sherrick, MD and Kathryn M. Basques, MSW, MSN, APN, PMHNP-BC
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
Presenter(s):
Greg Greenberg, M.D.
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™
Note: Once the live event has passed, please allow two weeks for the recording to be posted.
Webinar Description:
The treatment of opioid use disorder in rural communities can be challenging because of transportation, connectivity, and other barriers. Telemedicine can help with those barriers as well, but presents additional challenges. This talk will discuss some of the challenges related to the treatment of opioid use disorder in rural settings. We will discuss the benefits and pitfalls that come with the use of telemedicine. We will also discuss the challenges with obtaining urine toxicology screening and why it may not be a significant problem.
Administrative Staff, Pharmacists, Pharmacy Technicians, Physician Assistants, Physicians, Psychiatrists
Legal and Policy, Buprenorphine, Medications, Methadone, Naltrexone, Opioids, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No
SAMHSA: Learn about the federal statutes, regulations, and guidelines that apply to medications for practitioners and opioid treatment programs (OTPs).
Physicians, Interprofessional Teams, Nurses, Physician Assistants, Psychiatrists, Students and Educators
Presenter(s):
Danae DiRocco, MD, MPH; and Chun Tong, MD; and Yngvild Olsen, MD, MPH
Credit Available:
CE Credit(s): No
Certificate: No
The Substance Abuse and Mental Health Services Administration (SAMHSA) has finalized an overhaul of opioid treatment programs (OTPs) that enshrines many flexibilities first implemented during the crisis response to the COVID pandemic. These changes represent the first significant change to methadone treatment in over 20 years. In this episode, we have Dr. Olsen return to our podcast to talk more about these important policy changes and what providers need to know. Dr. Yngvild Olsen is the director for the Center for Substance Abuse Treatment.
Administrative Staff, Counselors, Interprofessional Teams, Psychologists, Social Workers
Presenter(s):
Ed Hayes: Assistant Superintendent at Franklin County Sheriff’s Office, Administrative Director of the FCSO OTP and Rachel Katz, NP Director, Addiction Services, Friends of the Homeless (FOH), Medical Respite, CNP
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Transitioning from jails and prisons back into the community can be especially difficult for people with opioid use disorders (OUD). Research suggests that opioid use overdose increases dramatically within the first 30 days of citizens returning to the community. Further, individuals recently released from incarceration face a risk of opioid overdose ten times greater than the general public. During these transitions it is critical that people receive seamless and appropriate resources in order to prevent overdose and return to use. This proper transition can help lower health care costs, hospitalizations and emergency department visits, as well as decrease mortality and recidivism for justice-involved individuals, yet at this time only 13 states have sought Medicaid waivers to provide SUD services pre-release. Join us today as we explore how programs can successfully develop services to ensure returning citizens receive appropriate care to address OUD.
Credit Available:
CE Credit(s): No
Certificate: No
Which patients receiving methadone should be considered good candidates for transfer to buprenorphine? How should I transition a patient from methadone to buprenorphine?
Pregnancy, Buprenorphine, Medications, Methadone, MOUD During Pregnancy, Opioids, Opioids, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No
View Guidance.
Ethics, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Medications, Methadone, Methadone, Naltrexone, Naltrexone ...
Presenter(s):
Bobby Mukkamala, MD and Elizabeth Salisbury-Afshar, MD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™
Opioid use disorder is a chronic disease that affects many and can be effectively treated. Evidence-based treatment for opioid use disorder (OUD), as well as harm reduction initiatives, can help individuals maintain in treatment and mitigate risks of relapse. In this episode, we’ll discuss medications for opioid use disorder (MOUD) as well as OUD treatment considerations and standards of care. The discussion will also include barriers that can stand in the way of those seeking treatment.
Credit Available:
CE Credit(s): No
Certificate: No
Oral health is an essential part of overall health. Healthcare professionals who provide care to patients with possible Opioid Use Disorder (OUD) or Substance Use Disorders (SUD) need to be aware of the special considerations this population may experience. Use this resource to learn how dental professionals can identify patients who may be at high-risk for OUD and SUD, while seeking care in the dental setting.
Loading more
